GB2021593A - A Purified Cancer Associated Protein - Google Patents

A Purified Cancer Associated Protein

Info

Publication number
GB2021593A
GB2021593A GB7917107A GB7917107A GB2021593A GB 2021593 A GB2021593 A GB 2021593A GB 7917107 A GB7917107 A GB 7917107A GB 7917107 A GB7917107 A GB 7917107A GB 2021593 A GB2021593 A GB 2021593A
Authority
GB
United Kingdom
Prior art keywords
cadet
iac
associated protein
cancer associated
protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB7917107A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfred Benzon AS
Original Assignee
Alfred Benzon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Benzon AS filed Critical Alfred Benzon AS
Publication of GB2021593A publication Critical patent/GB2021593A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A purified protein (CaDet) which in SDS Page gradient shows a molecular weight of about 25,000 Daltons has been eluted from antibody affinity columns with immobilized antibodies specifically directed against the protein C1 IAC described in U.S. Patent No. 4,132,769, by elution with a detergent. CaDet reacts with anti C1 IAC in immunoprecipitation tests and, when used for immunization, CaDet gives increased titers of anti C1 IAC.
GB7917107A 1978-05-17 1979-05-16 A Purified Cancer Associated Protein Withdrawn GB2021593A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17

Publications (1)

Publication Number Publication Date
GB2021593A true GB2021593A (en) 1979-12-05

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7917107A Withdrawn GB2021593A (en) 1978-05-17 1979-05-16 A Purified Cancer Associated Protein

Country Status (15)

Country Link
JP (1) JPS5516291A (en)
AU (1) AU521404B2 (en)
BE (1) BE876301A (en)
DE (1) DE2919833A1 (en)
ES (1) ES480624A1 (en)
FI (1) FI791551A (en)
FR (1) FR2426055A1 (en)
GB (1) GB2021593A (en)
IT (1) IT7968046A0 (en)
LU (1) LU81273A1 (en)
NL (1) NL7903854A (en)
NO (1) NO791643L (en)
NZ (1) NZ190470A (en)
PT (1) PT69617A (en)
SE (1) SE7904276L (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0091784A2 (en) * 1982-04-07 1983-10-19 Baylor College of Medicine Products for use in treating cancer
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2121417A (en) * 1982-02-22 1983-12-21 Carlton Med Prod Antigens and antibodies useful in the detection of cancer
EP0091784A2 (en) * 1982-04-07 1983-10-19 Baylor College of Medicine Products for use in treating cancer
EP0091784A3 (en) * 1982-04-07 1984-07-11 Baylor College Of Medicine Products for use in treating cancer

Also Published As

Publication number Publication date
PT69617A (en) 1979-06-01
AU4717279A (en) 1979-11-22
ES480624A1 (en) 1980-08-16
NL7903854A (en) 1979-11-20
BE876301A (en) 1979-11-16
SE7904276L (en) 1979-11-18
LU81273A1 (en) 1979-09-10
JPS5516291A (en) 1980-02-04
NO791643L (en) 1979-11-20
FI791551A (en) 1979-11-18
NZ190470A (en) 1982-06-29
FR2426055A1 (en) 1979-12-14
AU521404B2 (en) 1982-04-01
IT7968046A0 (en) 1979-05-17
DE2919833A1 (en) 1979-11-29

Similar Documents

Publication Publication Date Title
ES2106195T3 (en) IGG AGLYCOSILATED ANTIBODY ANTI CD3.
EP0458841A4 (en) Method for the use and synthesis of peptides
EP0930365A3 (en) Binding domains in serrate protein
NZ239617A (en) Pharmaceutical compositions containing cross-linked homoconjugated monoclonal antibodies having at least two igg antibodies which bind to the same determinant
GB2128630A (en) Method of affinity purification employing monoclonal antibodies
HUT41836A (en) Process for preparing monoclonal antibodies cross-reactive and cross-protecting against p. aeruginosa serotypes
EP0359063A3 (en) Antibody having high affinity to hapten as antigen and immunogen for obtaining the same
IL92037A0 (en) Novel family of high affinity,modified antibodies for cancer treatment
GB2255637B (en) Separation method
AU664063B2 (en) CENP-B epitope
HU9602570D0 (en) Process for producing immunoglobulines from fractions produced with fractioning human blood-plasma
AU2707992A (en) Monoclonal antibodies to hepatitis c virus
GB2021593A (en) A Purified Cancer Associated Protein
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
ES2082132T3 (en) COMPOSITION CONTAINING AT LEAST TWO DIFFERENT ANTIBODIES OR FRAGMENTS OF THEM.
AU7796291A (en) High affinity antibodies to small peptides
Hudson et al. The use of column-bound B lymphocytes for absorption of antisera to T lymphocyte antigens
DE3273844D1 (en) Procedure for immunological determinations using two antibodies, the second antibody being purified by affinity chromatography, and supports therefor
EP0366684A4 (en) Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies.
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
WO1994021812A3 (en) Hepatitis b escape mutant specific binding molecules
ATE76082T1 (en) PURIFICATION METHOD FOR ANTIBODIES.
Arends [10] Purification of peroxidase-conjugated antibody for enzyme immunoassay by affinity chromatography on concanavalin A
AU1626492A (en) Monoclonal antibodies against the plasmin-antiplasmin complex, a method for the preparation thereof and the use thereof
ZA868673B (en) Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)